Concepedia

Bertrand Rochat

BR

Statistics

Publications

44

Citations

3.3K

H-Index

32

Active since

1995

Affiliations

University Hospital of Lausanne(Current)

University of Lausanne

Hôpital de Cery

Hôpital Orthopédique de la Suisse Romande

Thermo Fisher Scientific (Germany)

Bertrand Rochat is an author at University Hospital of Lausanne specializing in pharmacology, mass spectrometric analysis, and medicine.

ORCID

Publications per year

1995–2018

44

Publications

44

Human CYP2B6: expression, inducibility and catalytic activities.

Laurence Gervot, Bertrand Rochat, Jean‐Charles Gautier et al. · PubMed · 1999 · 245 citations

, , +17

Human CYP2B6

Laurence Gervot, Bertrand Rochat, Jean‐Charles Gautier et al. · Pharmacogenetics · 1999 · 214 citations

, , +17

Therapeutic Drug Monitoring of the new targeted anticancer agents imatinib, nilotinib, dasatinib, sunitinib, sorafenib and lapatinib by LC tandem mass spectrometry

Amina Haouala, Boris Zanolari, Bertrand Rochat et al. · Journal of Chromatography B · 2009 · 202 citations

, , +16

Human CYP1B1 and Anticancer Agent Metabolism: Mechanism for Tumor-Specific Drug Inactivation?

Bertrand Rochat, Janine M. Morsman, G I Murray et al. · Journal of Pharmacology and Experimental Therapeutics · 2001 · 201 citations

, , +17

Population pharmacokinetics of imatinib and the role of α<sub>1</sub>‐acid glycoprotein

Nicolas Widmer, Laurent A. Décosterd, Chantal Csajka et al. · British Journal of Clinical Pharmacology · 2006 · 193 citations · Full text

, , +13

1–5 of 44